Amsterdam Institute for Global Health and Development

What Amsterdam Institute for Global Health and Development does

Amsterdam Institute for Global Health and Development (AIGHD) is a non-profit research institute founded in 2007 and headquartered at Amsterdam UMC in the Netherlands. It operates as a joint institute of the University of Amsterdam and Vrije Universiteit Amsterdam, conducting collaborative, interdisciplinary research across six priority themes: antimicrobial drug resistance, chronic care and aging, economics of human development, health markets, infectious disease elimination, and urbanization and health. The institute maintains active research projects in over 30 countries, with particular depth in sub-Saharan Africa, and runs clinical research capacity networks including TESA (Southern Africa) and EACCR (East Africa).

AIGHD delivers outputs through three core pillars: research programs, education (Bachelor, Masters, PhD, internships, including the Erasmus Mundus Joint Doctorate), and policy/communications. Technical research modules include EpiGen Ethiopia (genomic epidemiology for pandemic preparedness), CAGE-TB (machine learning-based cough audio classification for TB triage), Stool4TB (novel stool-based qPCR diagnostics), Yellow4FLAVI (flavivirus vaccine immunogenicity research), TRiAD (drug-resistant TB triage), H-TEAM (HIV elimination in Amsterdam), and the Global TB Vaccine R&D Roadmap developed with WHO. The institute also organizes the annual INTEREST (HIV) Conference and Global Health Symposia.

AIGHD's revenue model is grant-based, with funding from European programs (EDCTP, Horizon Europe), the Bill & Melinda Gates Foundation, pharmaceutical companies (ViiV Healthcare, Janssen, Bristol-Myers Squibb, Gilead Sciences), and Dutch governmental bodies (ZonMw, Aidsfonds). The organization holds ANBI (Dutch public benefit organization) status and does not sell commercial products or services. Strategic positioning is anchored by the secretariat role in EGHRIN, direct WHO collaboration including STAG membership, and embedded partnerships with founding academic institutions.

Name

Amsterdam Institute for Global Health and Development

Legal name

Amsterdam Institute for Global Health & Development

Website

https://aighd.org

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

101–250 employees

Short description

AIGHD is a non-profit research institute jointly founded by the University of Amsterdam and Vrije Universiteit, conducting collaborative interdisciplinary global health research, education, and policy work across 30+ countries with a focus on infectious diseases, antimicrobial resistance, and health systems.

Ownership category

akta.pro rank

Product category

Global Health Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Social Sciences and Humanities (54172)

SIC

Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Disease-Specific Global Programs (HIV/TB/Malaria/NTDs) (HLAJAKAF)

akta.pro secondary industries

Infectious Disease & Pandemic Preparedness Vaccines (emerging pathogens) (HLAAAEAC), Data Integration, Interoperability & Reporting (ELR/HIE/CDC/NNDSS) (HLAJABAN), Infectious Disease Program Evaluation (e.g., HIV/TB/Malaria/STIs) (HLAJANAF)

Keywords

• Global health research
• Infectious disease diagnostics
• Clinical research capacity
• Health policy advocacy
• Global health education

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Others

Revenue model

1. Research Grants and Funding: AIGHD receives funding through competitive grants from European and international funding bodies to conduct collaborative global health research projects. Major funders include EDCTP (European and Developing Countries Clinical Trials Partnership), EU Horizon programs, and private foundations.
2. Educational Programs: The institute develops and delivers global health education at undergraduate, postgraduate, and professional levels, including the Erasmus Mundus Joint Doctorate Program and annual INTEREST Conference.
3. Conference and Event Management: AIGHD organizes the annual INTEREST (HIV) Conference and Global Health Symposia as platforms for knowledge sharing and community building in global health research.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

AIGHD conducts collaborative, interdisciplinary research on global health themes including antimicrobial resistance, infectious disease elimination, chronic care and aging, health economics, and urbanization and health. It delivers education programs at bachelor, master, PhD, and professional levels, and translates evidence into policy through partnerships with WHO, EDCTP, and national health agencies. Standalone project offerings include the EpiGen Ethiopia genomic surveillance platform, CAGE-TB AI cough analysis tool, Stool4TB pediatric TB diagnostic, Yellow4FLAVI vaccine research, the TB Vaccine Roadmap, the INTEREST HIV Conference, and Global Health Symposia.

Product overview

AIGHD operates as a cross-disciplinary research institute offering three interconnected core pillars: collaborative global health research programs spanning antimicrobial resistance, chronic disease, infectious disease elimination, and health systems; education programs at bachelor, masters, PhD, and professional levels; and policy & communication initiatives. The organization delivers specialized projects including the TB Vaccine Roadmap (developed with WHO), INTEREST HIV Conference, and Global Health Symposia. Technical research modules include EpiGen Ethiopia (genomic epidemiology), CAGE-TB (AI-powered cough audio classification for TB screening), Stool4TB (stool-based TB diagnostics), and Yellow4FLAVI (flavivirus vaccine research). The institute also coordinates clinical research networks including TESA (Southern Africa), EACCR (East Africa), and SPIN (AMR surveillance in Indonesia).

Differentiator

Problem solved

Functional benefit

Products and services

• Global Health Research Programs

Quantifiable outcome

• Reduced HIV diagnoses in Amsterdam from 941 (2015) to 664 (2018)
• +1 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Partnerships

17 partnerships are on record, tiered core and flagship.

• Amsterdam UMCcoreStrategic or Co-development PartnerFounding partner of AIGHD, hosting the institute's headquarters at its Meibergdreef location. Multiple collaborative research projects and shared faculty including Professor of Global Health positions.
• H-TEAM Consortium PartnerscoreStrategic or Co-development PartnerMulti-stakeholder consortium including Amsterdam health & technology institute, Amsterdam Public Health Service, Dutch Association of People Living with HIV, hospitals, and national institutes working to eliminate HIV transmission in Amsterdam.
• European & Developing Countries Clinical Trials Partnership (EDCTP)coreStrategic or Co-development PartnerPublic-public partnership between 16 African and 14 European countries supporting collaborative clinical research. EDCTP has commissioned AIGHD to develop the Global TB Vaccine R&D Roadmap.
• AMR-GlobalcoreStrategic or Co-development PartnerPublic partnership addressing antimicrobial resistance globally, coordinated by Constance Schultsz. Establishes relationships with academia and organizations to conduct sustainable collaborative research.
• European Global Health Research Institutes Network (EGHRIN)coreStrategic or Co-development PartnerAIGHD holds the secretariat position within this network of leading European research institutions promoting global health research and innovation advocacy.
• World Health Organization (WHO)flagshipStrategic or Co-development PartnerClose collaboration with WHO on TB Vaccine Roadmap development and WHO Guideline Development Group for Self-Care Interventions. Prof. Anita Hardon serves on WHO STAG.
• Clingendael Health InitiativecoreStrategic or Co-development PartnerFrank Cobelens co-founded this initiative bringing together Dutch stakeholders in global health to advocate for broader strategic approach to global health by the Netherlands Government.
• Stichting HIV MonitoringcoreStrategic or Co-development PartnerProf. Peter Reiss served as Director until April 2021. Organization publishes comprehensive HIV Monitoring Reports contributing to HIV epidemic control in the Netherlands.
• Ludwig Maximilians UniversitycoreTechnology or IntegrationPartner in Yellow4FLAVI project focused on dissecting YF17D immunogenicity for vaccine design.
• Institut Pasteur PariscoreTechnology or IntegrationPartner in Yellow4FLAVI project with research lead Giovanna Barba Spaeth from Institut Pasteur.
• TESA Network (Trial of Excellence in Southern Africa)coreStrategic or Co-development PartnerNetwork of 15 institutions from 9 African and 3 European countries working to strengthen clinical research capacities in Southern Africa for HIV, TB, and malaria.
• EACCR (East African Consortium for Clinical Research)coreStrategic or Co-development PartnerMulti-country consortium strengthening clinical research capacity in East Africa.
• Centre for Cellular and Molecular Platforms (C-CAMP) IndiacoreStrategic or Co-development PartnerLetter of intent between AMR-Global and C-CAMP marking formal collaboration between Dutch and Indian groups to accelerate AMR research and innovation.
• University of Cape TowncoreStrategic or Co-development PartnerMultiple collaborative projects including TECoARTe, Stool4TB, and TESA network involving the Desmond Tutu HIV Centre.
• Makerere UniversitycoreStrategic or Co-development PartnerPartner in Stool4TB project and other African research collaborations.
• VU University AmsterdamcoreStrategic or Co-development PartnerPartner in Erasmus Mundus Joint Doctorate Program and various research projects. Associated faculty include Prof. Bas van der Klaauw.
• London School of Hygiene and Tropical Medicine (LSHTM)coreStrategic or Co-development PartnerPartner in TVMTU microbicide trials capacity building and VALUE TB cost-effectiveness modeling.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• London School of Hygiene & Tropical Medicine: Leading UK-based global health research and postgraduate teaching institute. Directly comparable as a peer academic institution focused on infectious disease epidemiology, clinical trials in LMICs, and health policy, and already a named AIGHD partner in TVMTU and VALUE-TB projects.
• Barcelona Institute for Global Health (ISGlobal): Spain-based global health research institute combining infectious disease, maternal/child health, and environmental health R&D with policy translation. Highly comparable in mission, scale, and European global-health positioning to AIGHD.
• Institut Pasteur: French non-profit research institute focused on infectious diseases, vaccinology, and global health, with extensive LMIC research networks. AIGHD is already an Institut Pasteur partner on Yellow4FLAVI, and the two share a comparable R&D and policy-advocacy model.
• Swiss Tropical and Public Health Institute (Swiss TPH): Swiss-based institute linked to University of Basel conducting research and education in tropical and public health, with strong LMIC programs. Directly comparable as a European global health research and education institute of similar scale.
• Liverpool School of Tropical Medicine: UK-based global health and tropical medicine research and teaching institution with extensive LMIC research programs and clinical trials capacity. Highly comparable scope, especially on TB, malaria, and capacity building.
• Heidelberg Institute of Global Health (HIGH): University Hospital Heidelberg's global health institute focused on infectious disease, health systems, and clinical trials in LMICs. Comparable in mission, German/European academic positioning, and EDCTP/Horizon funding profile.

Broad incumbents

• Karolinska Institutet - Department of Global Public Health: Swedish medical university's global public health department conducting large-scale epidemiology and intervention research in LMICs. Comparable scope on infectious disease epidemiology and policy translation, though embedded within a much larger parent university.
• Johns Hopkins Bloomberg School of Public Health: Largest US-based school of public health with deep global health R&D portfolio including infectious disease, vaccine, and policy work. Comparable research themes (HIV, TB, AMR) but at materially greater scale than AIGHD.

Emerging players

• PharmAccess Foundation: Dutch non-profit foundation working on healthcare financing and quality improvement in sub-Saharan Africa; shares AIGHD's Amsterdam base and several staff (financial administrator Sabah Khalil serves both organizations). Comparable LMIC health-systems focus, though more operationally delivery-oriented than research-focused.
• Stichting HIV Monitoring (SHM): Dutch foundation tracking HIV outcomes in the Netherlands and a named AIGHD partner. Highly comparable niche focus on HIV monitoring/research, with overlap via former AIGHD-affiliated directors and joint publications.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/aighd

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amsterdam Institute for Global Health and Development